IL13 and deafness: In contrast, IL-13 and IL-9 concentrations were higher in patients with complete deafness (surditas, SDT) compared to patients with residual hearing (*p < 0.05; Figure 3A) although statistical significance was missed for IL-9 (p = 0.058).